Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma.
Reduced expression of ASRGL1, defined as <75% positively stained tumor cells, was significantly associated with poor prognosis.
»
02/24/15
Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma.
PDPN(+)CAFs invaded and promoted cancer cell invasion into the lung parenchyma.
»
08/29/14
Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer.
Methylation in the promoter region resulted in silencing of Endoglin.
»
03/12/15
RNAi-mediated RPL34 knockdown suppresses the growth of human gastric cancer cells.
RPL34 plays a critical role in cell proliferation.
»
06/15/15
Involvement of nuclear receptor RZR/RORγ in melatonin-induced HIF-1α inactivation in SGC-7901 human gastric cancer cells.
Melatonin suppresses HIF-1α accumulation and VEGF generation via inhibition of melatonin nuclear receptor RZR/RORγ.
»
07/16/15
Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
Methylation of E2BS3 and E2BS4 in OPSCC is associated with E2 integrity and viral physical status.
»
10/24/14
Downregulation of VMP1 confers aggressive properties to colorectal cancer.
Mechanisms may be related to the activation of the PI3K/Akt/ZO-1/E-cadherin pathway.
»
07/16/15
Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis.
High expression of COX-2, high co-expression of COX-2 and 5-LO, and a high Ki-67 index were significant predictors of shorter OS.
»
02/25/15
Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
ISL1 genes' promoter-associated island was more frequently methylated in recurrent and progressive high-grade tumours than their non-recurrent counterparts.
»
09/01/15
CDK4/6-inhibition controls proliferation of bladder cancer and transcription of RB1.
CDK4/6 inhibition is a potential therapeutic strategy for RB positive BLCA.
»
08/20/15
< Prev
Next >